Unternehmen HBM Healthcare Investments AG Swiss Exchange
Aktien
A12EJW
CH0257717097
HBMNE
Investitionsmanagement & Fondsbetreiber
Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
210 CHF | -0,24 % |
|
0,00 % | +15,51 % |
Kurzporträt
Mitarbeiterzahl: 700
Umsatz nach Geschäftsbereich
CHF in Millionen | 2023 | Gewichtung | 2024 | Gewichtung | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100,0
%
| -117 | 100,0 % | 3 | 100,0 % | -102,56 % |
Umsatz je Region
CHF in Millionen | 2023 | Gewichtung | 2024 | Gewichtung | Delta |
---|---|---|---|---|---|
Switzerland
100,0
%
| -117 | 100,0 % | 3 | 100,0 % | -102,56 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Andreas Wicki
CEO | Chief Executive Officer | 64 | 01.07.01 |
Erwin Troxler
DFI | Director of Finance/CFO | 54 | 01.11.11 |
Benedikt Suter
SEC | Corporate Secretary | 60 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 68 | 01.06.09 | |
Elaine Jones
BRD | Director/Board Member | 69 | 18.06.21 |
Mario Giuliani
BRD | Director/Board Member | 52 | 01.01.12 |
Rudolf Lanz
BRD | Director/Board Member | 74 | 01.01.03 |
Benedikt Suter
SEC | Corporate Secretary | 60 | - |
Stella Xu
BRD | Director/Board Member | 53 | 01.06.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 6 960 000 | 5 671 334 ( 81,48 %) | 92 270 ( 1,326 %) | 81,48 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
BENITEC BIOPHARMA INC. 8,98% | 841 395 | 8,98% | 6 436 672 $ |
2 910 | 0,04% | 670 931 $ |
Unternehmenskontakt
![Straße HBM Healthcare Investments AG(HBMNE)](https://cdn.zonebourse.com/static/address/18445332.png)
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Swixx Biopharma SA
![]() Swixx Biopharma SA BiotechnologyHealth Technology Swixx Biopharma SA provides marketing and sales, regulatory, medical affairs, cold chain, logistic services to pharmaceutical companies. Its services also include receivables, collection, FX coverage, risk management, compliance, and reimbursement and market access. The company was founded by Petr Nemec and Robert Stuart Swanson in 2013 and is headquartered in Baar, Switzerland. |
Biotechnology
|
HBM Healthcare Investments (Cayman) Ltd.
![]() HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Part of HBM Partners AG, HBM Healthcare Investments (Cayman) Ltd. provides healthcare services. The company is based in George Town, Cayman Islands. Andreas Wicki has been the CEO of the company since 2001. |
Hospital/Nursing Management
|
HBM Private Equity India
![]() HBM Private Equity India Financial ConglomeratesFinance Part of HBM Partners AG, HBM Private Equity India is an Indian company that provides investment services. |
Financial Conglomerates
|
Sektor
![Analystenschätzungen](/images/consensus_flch.gif)
Verlauf des Gewinns je Aktie
Jahresgewinne - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
+17,40 % | 3,13 Mrd. | |
+12,50 % | 1,76 Mrd. | |
-11,54 % | 1,2 Mrd. | |
+44,09 % | 938 Mio. | |
+7,60 % | 652 Mio. | |
+33,76 % | 564 Mio. | |
-4,17 % | 504 Mio. | |
+33,23 % | 483 Mio. | |
+78,27 % | 330 Mio. |
- Börse
- Aktien
- 984345 Aktie
- A12EJW Aktie
- Unternehmen HBM Healthcare Investments AG